Screener
Integra LifeSciences IART Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Current portion of borrowings under senior credit facility | $43,594 | $38,750 |
| Current portion of borrowings under securitization facility | — | 87,800 |
| Current portion of lease liability - operating leases | 13,920 | 14,019 |
| Accounts payable, trade | 82,637 | 95,726 |
| Contract liabilities | 11,699 | 11,463 |
| Income tax payable | 3,236 | 3,651 |
| Accrued compensation | 68,177 | 74,079 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's operating lease liabilities (current)?
- Integra LifeSciences (IART) reported operating lease liabilities (current) of $13.92M in Q2 2026.
- How has Integra LifeSciences's operating lease liabilities (current) changed year-over-year?
- Integra LifeSciences's operating lease liabilities (current) decreased by 1.8% year-over-year, from $14.18M to $13.92M.
- What is the long-term trend for Integra LifeSciences's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Integra LifeSciences's operating lease liabilities (current) has grown at a 1.8% compound annual growth rate (CAGR), from $12.82M to $14.02M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Integra LifeSciences's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude